Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Arnesen

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Scandinavian Cardiovascular Journal : SCJ|June 19, 2001
Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variablesO Johansen, M Abdelnoor, M Brekke, et al.
Thrombosis Research|May 14, 2008
Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatmentE Brodin, I Seljeflot, H Arnesen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparinH Arnesen, O E Dahl, T Aspelin, et al.
Metabolism: Clinical and Experimental|March 21, 1998
Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placeboI Seljeflot, A Moan, T Aspelin, et al.
European Journal of Clinical Nutrition|November 25, 2005
Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking StudyI Ellingsen, E M Hjerkinn, H Arnesen, et al.
Journal of Hypertension|September 1, 1996
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivityA Moan, A Høieggen, I Seljeflot, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patientsI Seljeflot, J R Larsen, K Dahl-Jørgensen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 19, 2022
Effect of Revascularization on Exercise-Induced Changes in Cardiac and Prothrombotic Biomarkers in Patients with Coronary Artery DiseaseC H Hansen, J Cwikiel, V Bratseth, et al.
Haemostasis|April 8, 2000
Combined administration of dextran 70 and dalteparin does not increase perioperative blood loss compared to dextran 70 alone in major orthopedic surgeryO E Dahl, H K Walsoe, T Aspelin, et al.
European Journal of Clinical Investigation|July 13, 2005
Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart diseaseA Schumacher, I Seljeflot, A B Lerkerød, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Scandinavian Cardiovascular Journal : SCJ|June 19, 2001
Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variablesO Johansen, M Abdelnoor, M Brekke, et al.
Thrombosis Research|May 14, 2008
Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatmentE Brodin, I Seljeflot, H Arnesen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparinH Arnesen, O E Dahl, T Aspelin, et al.
Metabolism: Clinical and Experimental|March 21, 1998
Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placeboI Seljeflot, A Moan, T Aspelin, et al.
European Journal of Clinical Nutrition|November 25, 2005
Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking StudyI Ellingsen, E M Hjerkinn, H Arnesen, et al.
Journal of Hypertension|September 1, 1996
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivityA Moan, A Høieggen, I Seljeflot, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patientsI Seljeflot, J R Larsen, K Dahl-Jørgensen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 19, 2022
Effect of Revascularization on Exercise-Induced Changes in Cardiac and Prothrombotic Biomarkers in Patients with Coronary Artery DiseaseC H Hansen, J Cwikiel, V Bratseth, et al.
Haemostasis|April 8, 2000
Combined administration of dextran 70 and dalteparin does not increase perioperative blood loss compared to dextran 70 alone in major orthopedic surgeryO E Dahl, H K Walsoe, T Aspelin, et al.
European Journal of Clinical Investigation|July 13, 2005
Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart diseaseA Schumacher, I Seljeflot, A B Lerkerød, et al.
Pageof 17